rs201246220
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138425.4(C12orf57):c.37G>A(p.Ala13Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000196 in 1,614,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_138425.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152242Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000795 AC: 20AN: 251446Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135904
GnomAD4 exome AF: 0.000207 AC: 303AN: 1461862Hom.: 0 Cov.: 33 AF XY: 0.000191 AC XY: 139AN XY: 727234
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152360Hom.: 0 Cov.: 34 AF XY: 0.0000671 AC XY: 5AN XY: 74512
ClinVar
Submissions by phenotype
Temtamy syndrome Uncertain:3
- -
- -
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 13 of the C12orf57 protein (p.Ala13Thr). This variant is present in population databases (rs201246220, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with C12orf57-related conditions. ClinVar contains an entry for this variant (Variation ID: 575714). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.37G>A (p.A13T) alteration is located in exon 1 (coding exon 1) of the C12orf57 gene. This alteration results from a G to A substitution at nucleotide position 37, causing the alanine (A) at amino acid position 13 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at